MILITE, Ciro
 Distribuzione geografica
Continente #
AS - Asia 6.211
NA - Nord America 5.101
EU - Europa 1.603
SA - Sud America 438
Continente sconosciuto - Info sul continente non disponibili 191
AF - Africa 54
OC - Oceania 3
Totale 13.601
Nazione #
US - Stati Uniti d'America 4.961
HK - Hong Kong 4.449
SG - Singapore 817
IT - Italia 740
CN - Cina 357
BR - Brasile 351
RU - Federazione Russa 198
VN - Vietnam 193
DE - Germania 133
UA - Ucraina 120
TR - Turchia 94
IN - India 74
IE - Irlanda 72
FR - Francia 69
CA - Canada 65
FI - Finlandia 59
GB - Regno Unito 55
KR - Corea 55
SE - Svezia 52
BD - Bangladesh 47
AR - Argentina 34
MX - Messico 32
JP - Giappone 27
IQ - Iraq 21
PL - Polonia 20
ES - Italia 17
NL - Olanda 15
VE - Venezuela 15
ZA - Sudafrica 14
JM - Giamaica 13
PK - Pakistan 13
AT - Austria 11
ID - Indonesia 11
CO - Colombia 10
CZ - Repubblica Ceca 10
MA - Marocco 9
CL - Cile 8
EC - Ecuador 8
DZ - Algeria 7
UZ - Uzbekistan 7
GR - Grecia 6
IL - Israele 6
PH - Filippine 6
AL - Albania 5
GT - Guatemala 5
MY - Malesia 5
PA - Panama 5
PE - Perù 5
SA - Arabia Saudita 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
LT - Lituania 4
RO - Romania 4
BO - Bolivia 3
CR - Costa Rica 3
ET - Etiopia 3
HN - Honduras 3
JO - Giordania 3
KE - Kenya 3
NI - Nicaragua 3
PR - Porto Rico 3
PY - Paraguay 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
EE - Estonia 2
EG - Egitto 2
EU - Europa 2
LB - Libano 2
LU - Lussemburgo 2
LY - Libia 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SN - Senegal 2
AO - Angola 1
BB - Barbados 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
GE - Georgia 1
GH - Ghana 1
GN - Guinea 1
KH - Cambogia 1
LV - Lettonia 1
MN - Mongolia 1
MV - Maldive 1
MZ - Mozambico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
QA - Qatar 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 13.412
Città #
Hong Kong 4.436
Ann Arbor 707
Ashburn 518
San Jose 484
Singapore 403
Dallas 330
Chandler 314
Woodbridge 265
Milan 220
Houston 188
Princeton 187
Jacksonville 175
Council Bluffs 135
Wilmington 135
Beijing 124
Salerno 115
Izmir 73
The Dalles 71
Dublin 68
New York 68
Munich 64
Rome 63
Ho Chi Minh City 59
Santa Clara 59
São Paulo 58
Lauterbourg 51
Boardman 43
Dearborn 40
Los Angeles 40
Andover 38
Dong Ket 38
Nanjing 33
Hanoi 30
Columbus 28
Moscow 26
Tokyo 25
Chicago 24
Figino 23
Turku 23
Orem 22
Fairfield 20
Toronto 20
Naples 19
Pellezzano 19
Fisciano 18
Warsaw 18
Brooklyn 17
Montreal 17
Phoenix 16
Denver 15
Philadelphia 15
Shenyang 15
Basingstoke 14
Hebei 14
Pune 14
Helsinki 13
Memphis 13
Mexico City 13
Rio de Janeiro 12
Atlanta 11
Changsha 11
Redwood City 11
San Diego 11
San Francisco 11
Belo Horizonte 10
Norwalk 10
Nuremberg 10
Frankfurt am Main 9
Seattle 9
Baghdad 8
Baronissi 8
Brno 8
Buffalo 8
Charlotte 8
Chennai 8
Hải Dương 8
Johannesburg 8
Nanchang 8
Seoul 8
Stockholm 8
Turin 8
Amsterdam 7
Caserta 7
Catania 7
Florence 7
Haiphong 7
Shanghai 7
Tashkent 7
Washington 7
Ankara 6
Boston 6
Düsseldorf 6
Falls Church 6
Indianapolis 6
Joinville 6
Kingston 6
London 6
Munro 6
Palermo 6
Scafati 6
Totale 10.426
Nome #
Design, synthesis and biological evaluation of new selective arginine methyltransferases (PRMTs) Inhibitors 1.286
Synthesis and cytotoxic activity evaluation of 2,3-thiazolidin-4-one derivatives on human breast cancer cell lines 726
ChemInform Abstract: Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors 696
Prodrug Approach to Exploit (S) Alanine as Arginine Mimic Moiety in the Development of Protein Arginine Methyltransferase 4 Inhibitors 542
Successes and challenges in the development of BD1-selective BET inhibitors: a patent review 451
Nutraceutical properties and polyphenolic profile of berry skin and wine of Vitis vinifera L. (cv. Aglianico) 390
Modulation of the Activity of Histone Acetyltransferases by Long Chain Alkylidene-malonates (LoCAMs) 383
FROM GARCINOL TO BARBITURIC ACID DERIVATIVES: DEVELOPMENT OF NEW AND SELECTIVE P300 INHIBITORS. 282
Identification of Structural Features of 2-Alkylidene-1,3-Dicarbonyl Derivatives that Induce Inhibition and/or Activation of Histone Acetyltransferases KAT3B/p300 and KAT2B/PCAF 277
Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor 276
A novel cell-permeable, selective and noncompetitive inhibitor of KAT3 histone acetyltransferases from a combined molecular pruning/classical isosterism approach 267
Design, Synthesis, and Evaluation of New Tripeptides as COX-2 Inhibitors 257
A continuous-flow synthesis of 1,4-benzodiazepin-5-ones, privileged scaffolds for drug discovery 237
CARM1 modulators affect epigenome of stem cells and change morphology of nucleoli 223
Identification of Small-Molecule Enhancers of Arginine Methylation Catalyzed by Coactivator-Associated Arginine Methyltransferase 1 213
Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans 206
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL G9A INHIBITORS FROM A SCAFFOLD HOPPING APPROACH 201
Use of Microscale Thermophoresis (MST) for Studying binding interactions of PRSet-7/SETD8 with small molecule specific inhibitors EPI-9 and EPI-23. 198
Design, Synthesis and Biological Evaluation of Carboxy Analogues of Arginine Methyltransferase Inhibitor 1 (AMI-1) 195
Design, synthesis and biological evaluation of pyrrole derivatives as coactivator associated arginine methyltransferase 1 (CARM1) inhibitors 192
Design, synthesis and biological evaluation of novel G9a inhibitors with improved brain permeability from a scaffold hopping approach 191
Biomolecular and biophysical approaches to interrogate p300: a platform for drug discovery. 185
Inside Cover: Identification of Structural Features of 2-Alkylidene-1,3-Dicarbonyl Derivatives that Induce Inhibition and/or Activation of Histone Acetyltransferases KAT3B/p300 and KAT2B/PCAF (ChemMedChem 1/2015) 184
Design, synthesis and in vitro evaluation of bivalent chemical probes for bromo and extra-terminal domain (BET) proteins 182
Discovery of a novel chemotype of histone lysine methyltransferase EHMT1/2 (GLP/G9a) inhibitors: rational design, synthesis, biological evaluation and co-crystal structure 178
Discovery of benzo[d]imidazole-6-sulfonamides as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain 173
Highly efficient synthesis and chemical separation of 5-amino- and 7-amino-4-hydroxy-2-naphthoic acids 172
Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors 171
ChemInform Abstract: A Continuous-Flow Synthesis of 1,4-Benzodiazepin-5-ones, Privileged Scaffolds for Drug Discovery 170
Straightforward, Metal-free, and Stereoselective Synthesis of 9-Oxo- and 10-Hydroxy-2(E)-decenoic acids, Important Components of Honeybee (Apis mellifera) secretions 169
Developing Type II F508del-CFTR correctors with a protective effect against respiratory viruses 168
Structure–Activity Relationship Refinement and Further Assessment of 4-phenylquinazoline-2-carboxamide Translocator Protein (TSPO) Ligands as Antiproliferative Agents in Human Glioblastoma Tumors. 167
Regulation of USP37 Expression by REST-associated G9a-dependent Histone Methylation 162
Expanding the quinazoline ring to 3H-benzo[e][1,4]diazepine: development of new and selective G9a inhibitors 160
Identification of new KDM4 inhibitors through a HTS and hit refinement strategy 159
Identification of Limonol Derivatives as Heat Shock Protein 90 (Hsp90) Inhibitors through a Multidisciplinary Approach 157
Identification of new inhibitors of PRMTs by a multi-substrate-adduct approach 154
Identification of new inhibitors of PRMTs by a multi-substrate-adduct approach 148
p300/CBP-Associated Factor Selectively Regulates the Extinction of Conditioned Fear 146
Modulation of cell differentiation, proliferation, and tumor growth by dihydrobenzyloxopyrimidine non-nucleoside reverse transcriptase inhibitors. 143
A continuous-flow synthesis of 1,4-benzodiazepin-5-ones, privileged scaffolds for drug discovery. 141
From garcinol to barbituric acid derivatives: development of a novel cell-permeable, selective, and noncompetitive inhibitor of KAT3 histone acetyltransferases. 141
Synthesis and Biological Evaluation of 4-Phenylquinazoline-2-carboxamides Designed as a Novel Class of Potent Ligands of the Translocator Protein 140
Highly Enantioselective Organocatalytic α-Amination Reactions of Aryl Oxindoles: Developing Designer Multifunctional Alkaloid Catalysts 136
The emerging role of lysine methyltransferase SETD8 in human diseases 136
Exploiting the 4-Phenylquinazoline Scaffold for the Development of High Affinity Fluorescent Probes for the Translocator Protein (TSPO) 134
Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach 134
IDENTIFICATION OF NEW KDM4 INHIBITORS THROUGH A HTS AND HIT REFINEMENT STRATEGY 131
Reverse transcriptase inhibitors promote the remodeling of nuclear architecture and induce autophagy in prostate cancer cells 126
Synthesis and evaluation of new TSPO PET radioligands with low sensitivity to human genotype 124
Age-dependent attenuation of spatial memory deficits by the histone acetyltransferase p300/CBP-associated factor (PCAF) in 3xTG Alzheimer's disease mice 123
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 120
Lysine methyltransferase inhibitors: where we are now. 118
The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells 107
New pyridobenothiazolone derivatives display nanomolar pan‐serotype anti‐DENV activity 99
Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies 95
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 82
The Lysine Acetyltransferase PCAF Functionally Interacts with Estrogen Receptor Alpha in the Hippocampus of Gonadally Intact Male - but not Female - Rats to Enhance Short-term Memory 80
NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors 76
Microwave-Assisted Aminoalkylation of Phenols via Mustard Carbonate Analogues 76
Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization 72
Sulfonyl Anthranilic Acid Analogues Display Pan-Serotype Anti-Dengue Activity by Downregulating the Expression of Ribosomal Proteins Encoded by 5′-Terminal Oligopyrimidine Motif-Containing mRNA 64
Patent evaluation of WO2019209182 (A1) 2019-10-31 (Conjugated Oligoelectrolytes as Antimicrobial Agents) 61
Identification of 2‐Substituted‐3‐Hydroxy‐2,3‐Dihydroquinazolin‐4(1 H ) Ones as Cell‐Active Inhibitors of KDM4A Lysine Demethylase 57
Coactivator-associated arginine methyltransferase 1 (CARM1) inhibitors: a patenting perspective (2018-present) 52
2‐Phenylquinolines Exhibit Anti‐Severe Acute Respiratory Syndrome Coronavirus‐2 Activity Through the Nonstructural Protein 13 Helicase Inhibition 38
Design, synthesis and biological evaluation of new small molecule modulators of Arginine methyltransferases 37
Discovery of High-Affinity Peptide Ligands Targeting the SPIN1 Tudor 3 Domain Via a Minimalist Pruning Strategy 30
Targeting Copper in Cancer: Chelators to Counteract Cuproplasia and Ionophores to Promote Cuproptosis 24
Targeting PRMTs with Small-Molecule Inhibitors: A Comprehensive Review 10
Totale 13.601
Categoria #
all - tutte 35.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.406


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022369 0 0 0 6 10 15 8 19 43 53 63 152
2022/2023673 57 67 18 90 73 142 11 63 108 4 31 9
2023/2024309 16 35 26 11 17 58 15 12 1 19 12 87
2024/20251.160 21 22 22 64 109 111 192 90 166 69 155 139
2025/20267.558 988 2.169 1.831 240 403 187 483 109 281 361 117 389
2026/20271.234 170 150 374 540 0 0 0 0 0 0 0 0
Totale 13.601